trial

REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention

NCTId NCT06251908
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 300 (estimated)
Sponsored by Amager Hospital
Primary completion 2026-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
300 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-02-12
Primary completion
2026-10
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
RewritalizeStandard mental health care

Sponsors

Amager HospitalLead Sponsor

Investigators

1
Lene F Eplov, MD, PhdPrincipal Investigator

Sites

6 total
Rønne, DenmarkCopenhagen, DenmarkCopenhagen, DenmarkHillerød, DenmarkHolbæk, DenmarkVordingborg, Denmark

Facts & assertions

4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2026-10
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Rewritalize
drug
Standard mental health care
drug
lead_sponsor
Amager Hospital
company
indication
Bipolar Disorder
indication
Personality Disorder, Borderline
indication
Schizophreniform Disorders
indication
investigator
Lene F Eplov, MD, Phd
person